Onconic Therapeutics Inc.

₩11,680As of Sun 8 Nov 2026, 12:00 UTC
TPEx:4197Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (1.93%)
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM (31.86%)
Mkt cap ₩530.4B
ROIC (2.76%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩14,181
21.41%
(11.47%)
Hold 4|2|10|1|9
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
236.10
236.44
248.20
253.65
28.46%
22.24%
16.27%
6.11%
Revenue₩B
27.93
28.73
28.42
29.89
6.53%
12.37%
6.34%
11.99%
Peers (US$6.746M)
Cap (US$)
PE
8.881M
14.01x
5.675M
18.97x
Capital
TTM
5Y
10Y
Leveragex
1.072
0.193
0.195
EBIT/Intx
1.317
0.417
0.378
Own earn%
(60.44)
46.99
37.33
Sh yield%
12.82
49.40
48.78
Owners
Insiders/Inst%
13.40
35.11
Short interest%
1.79
SBC / revenue%
1.68
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
34–42
$1 testx
−0.1
Incr. ROIC%
3